
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CD4+ T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy
Jennifer R. Richardson, Anna Schöllhorn, Cécile Gouttefangeas, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 596-596
Open Access | Times Cited: 43
Jennifer R. Richardson, Anna Schöllhorn, Cécile Gouttefangeas, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 596-596
Open Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
CD4+ T cells in cancer
Daniel E. Speiser, Obinna Chijioke, Karin Schaeuble, et al.
Nature Cancer (2023) Vol. 4, Iss. 3, pp. 317-329
Closed Access | Times Cited: 231
Daniel E. Speiser, Obinna Chijioke, Karin Schaeuble, et al.
Nature Cancer (2023) Vol. 4, Iss. 3, pp. 317-329
Closed Access | Times Cited: 231
Biomaterials tools to modulate the tumour microenvironment in immunotherapy
Yu Chao, Zhuang Liu
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 2, pp. 125-138
Closed Access | Times Cited: 130
Yu Chao, Zhuang Liu
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 2, pp. 125-138
Closed Access | Times Cited: 130
Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms
Ganping Wang, Ming Zhang, Maosheng Cheng, et al.
Cancer Letters (2021) Vol. 507, pp. 55-69
Open Access | Times Cited: 74
Ganping Wang, Ming Zhang, Maosheng Cheng, et al.
Cancer Letters (2021) Vol. 507, pp. 55-69
Open Access | Times Cited: 74
Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects
Salvatore Cortellino, Alessandro Raveane, Claudia Chiodoni, et al.
Cell Reports (2022) Vol. 40, Iss. 8, pp. 111256-111256
Open Access | Times Cited: 42
Salvatore Cortellino, Alessandro Raveane, Claudia Chiodoni, et al.
Cell Reports (2022) Vol. 40, Iss. 8, pp. 111256-111256
Open Access | Times Cited: 42
T Cells in Colorectal Cancer: Unravelling the Function of Different T Cell Subsets in the Tumor Microenvironment
Ziwen Zheng, Thomas Wieder, Bernhard Mauerer, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11673-11673
Open Access | Times Cited: 32
Ziwen Zheng, Thomas Wieder, Bernhard Mauerer, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11673-11673
Open Access | Times Cited: 32
Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy
Yu Huang, Hui Fan, Huihui Ti
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 2, pp. 100902-100902
Open Access | Times Cited: 8
Yu Huang, Hui Fan, Huihui Ti
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 2, pp. 100902-100902
Open Access | Times Cited: 8
Regulation of T Cells in Cancer by Nitric Oxide
Inesa Navasardyan, Benjamin Bonavida
Cells (2021) Vol. 10, Iss. 10, pp. 2655-2655
Open Access | Times Cited: 43
Inesa Navasardyan, Benjamin Bonavida
Cells (2021) Vol. 10, Iss. 10, pp. 2655-2655
Open Access | Times Cited: 43
Antitumor Mechanisms of Molecules Secreted by Trypanosoma cruzi in Colon and Breast Cancer: A Review
Soheil Sadr, Shakila Ghiassi, Narges Lotfalizadeh, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 15, pp. 1710-1721
Closed Access | Times Cited: 20
Soheil Sadr, Shakila Ghiassi, Narges Lotfalizadeh, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 15, pp. 1710-1721
Closed Access | Times Cited: 20
Assessing the causal relationship between 731 immunophenotypes and the risk of lung cancer: a bidirectional mendelian randomization study
Ming Xu, Chengkai Li, Liyan Xiang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Ming Xu, Chengkai Li, Liyan Xiang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Interferon-driven Metabolic Reprogramming and Tumor Microenvironment Remodeling
Tzu-Hsuan Chang, Ping‐Chih Ho
Immune Network (2025) Vol. 25, Iss. 1
Open Access
Tzu-Hsuan Chang, Ping‐Chih Ho
Immune Network (2025) Vol. 25, Iss. 1
Open Access
Mechanistic insights into pachymic acid’s action on triple-negative breast Cancer through TOP2A targeting
Ming Liu, Li Zheng, Yang Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Ming Liu, Li Zheng, Yang Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Role of CD4+ T cells in cancer immunity: a single-cell sequencing exploration of tumor microenvironment
Qi An, Li Duan, Yuanyuan Wang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Qi An, Li Duan, Yuanyuan Wang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Development and validation of prognostic and diagnostic models utilizing immune checkpoint-related genes in public datasets for clear cell renal cell carcinoma
Bin Zhao, Shi Fu, Yuanlong Shi, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Bin Zhao, Shi Fu, Yuanlong Shi, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges
Marco Palma
Vaccines (2025) Vol. 13, Iss. 4, pp. 344-344
Open Access
Marco Palma
Vaccines (2025) Vol. 13, Iss. 4, pp. 344-344
Open Access
Multiplexed imaging mass cytometry reveals distinct tumor-immune microenvironments linked to immunotherapy responses in melanoma
Xu Xiao, Qian Guo, Chuanliang Cui, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 16
Xu Xiao, Qian Guo, Chuanliang Cui, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 16
Implications of single-cell immune landscape of tumor microenvironment for the colorectal cancer diagnostics and therapy
Ahmad Alzamami
Medical Oncology (2023) Vol. 40, Iss. 12
Closed Access | Times Cited: 9
Ahmad Alzamami
Medical Oncology (2023) Vol. 40, Iss. 12
Closed Access | Times Cited: 9
Tumor-Specific CD4+ T Cells Restrain Established Metastatic Melanoma by Developing Into Cytotoxic CD4– T Cells
Qiao Liu, Lisha Wang, Huayu Lin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Qiao Liu, Lisha Wang, Huayu Lin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Osteoclasts and Probiotics Mediate Significant Expansion, Functional Activation and Supercharging in NK, γδ T, and CD3+ T Cells: Use in Cancer Immunotherapy
Kawaljit Kaur, Anahid Jewett
Cells (2024) Vol. 13, Iss. 3, pp. 213-213
Open Access | Times Cited: 2
Kawaljit Kaur, Anahid Jewett
Cells (2024) Vol. 13, Iss. 3, pp. 213-213
Open Access | Times Cited: 2
Deciphering CD4+ T cell‐mediated responses against cancer
Catherine Kirkpatrick, Yong‐Chen Lu
Molecular Carcinogenesis (2024) Vol. 63, Iss. 7, pp. 1209-1220
Closed Access | Times Cited: 2
Catherine Kirkpatrick, Yong‐Chen Lu
Molecular Carcinogenesis (2024) Vol. 63, Iss. 7, pp. 1209-1220
Closed Access | Times Cited: 2
Comprehensive integrated single-cell RNA sequencing analysis of brain metastasis and glioma microenvironment: Contrasting heterogeneity landscapes
Seyedeh Fatemeh Sajjadi, Najmeh Salehi, Mehdi Sadeghi
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0306220-e0306220
Open Access | Times Cited: 2
Seyedeh Fatemeh Sajjadi, Najmeh Salehi, Mehdi Sadeghi
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0306220-e0306220
Open Access | Times Cited: 2
Irradiation Mediates IFNα and CXCL9 Expression in Non-Small Cell Lung Cancer to Stimulate CD8+ T Cells Activity and Migration toward Tumors
Chun‐Chia Cheng, Yi‐Fang Chang, Ai‐Sheng Ho, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1349-1349
Open Access | Times Cited: 13
Chun‐Chia Cheng, Yi‐Fang Chang, Ai‐Sheng Ho, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1349-1349
Open Access | Times Cited: 13
Advancements and Challenges in Personalized Therapy for BRAF-Mutant Melanoma: A Comprehensive Review
Abdulaziz Shebrain, Omer A. Idris, Ali Jawad, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5409-5409
Open Access | Times Cited: 1
Abdulaziz Shebrain, Omer A. Idris, Ali Jawad, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5409-5409
Open Access | Times Cited: 1
Making the effect visible – OX40 targeting nanobodies for in vivo imaging of activated T cells
Desiree I. Frecot, Simone Blaess, Teresa R. Wagner, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Desiree I. Frecot, Simone Blaess, Teresa R. Wagner, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
ZWINT is a Promising Therapeutic Biomarker Associated with the Immune Microenvironment of Hepatocellular Carcinoma
Tong Lin, Yingzhao Zhang, Zhimei Lin, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 7487-7501
Open Access | Times Cited: 11
Tong Lin, Yingzhao Zhang, Zhimei Lin, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 7487-7501
Open Access | Times Cited: 11
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection
Ann‐Kathrin Hartmann, Joschka Bartneck, Jonas Pielenhofer, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Ann‐Kathrin Hartmann, Joschka Bartneck, Jonas Pielenhofer, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4